VenoVision
VenoVision is a contactless, AI-driven, cardiopulmonary monitoring platform. VenoVision helps reduce costly cardiac ICU admissions and improve patient stability at discharge by providing medical teams with continuous hemodynamic assessment. Insights previously limited to cardiac catheterizations can now be non-invasively captured by our contactless, thermal imaging monitoring device.
VenoVision
VenoVision is a contactless, AI-driven, cardiopulmonary monitoring platform. VenoVision helps reduce costly cardiac ICU admissions and improve patient stability at discharge by providing medical teams with continuous hemodynamic assessment. Insights previously limited to cardiac catheterizations can now be non-invasively captured by our contactless, thermal imaging monitoring device.
TL;DR
Product: VVC-100 contactless thermal-imaging, ML-driven hemodynamic monitor
Use case: Non-invasive assessment of central venous pressure and waveform patterns for heart-failure and at-risk patients
Founding / Origin: Conceptualized in the BioDesign Israel program in collaboration with Hebrew University clinical centers
Location (reported): Dallas, Texas (company profile listings)
Funding signals: Seed $30,000 (Health Wildcatters, 2022); non-equity assistance from LvlUp Ventures (May 6, 2025)
Company Overview
Problem Domain
Cardiopulmonary / hemodynamic monitoring for heart-failure and at-risk patients across care settings (including remote/patient monitoring).
Founded
2016
Industry
Medical devices / Healthtech
Tech Stack
Funding Track Record
30000.00
Investor Signal
“Received seed-stage and non-equity assistance from investors including Health Wildcatters and LvlUp Ventures”